SBI Securities Co., Ltd. MRVI Maravai LifeSciences Holdings Inc A

Ownership history in SBI Securities Co., Ltd.  ·  7 quarters on record

AI Ownership Summary

SBI Securities Co., Ltd. reported Maravai LifeSciences Holdings Inc A (MRVI) in 7 quarterly 13F filings from 2024 Q4 through 2026 Q2. The latest visible filing shows MRVI at 0.00% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this MRVI ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was SBI Securities Co., Ltd.'s position in Maravai LifeSciences Holdings Inc A, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q2

MRVI was reported at 0.00% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.0% in 2024 Q4

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2024 Q4 to 2026 Q2

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

How SBI Securities Co., Ltd. held MRVI — position size vs. price
% of Fund (quarterly)    MRVI price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 7 quarters  
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q2 UNCHANGED 311 0% 0.00% $2K 2026-07-23 $7.05
2026 Q1 UNCHANGED 311 0% 0.00% $880 2026-04-28 $3.56
2025 Q4 REDUCED 24.9% -12.9% 311 -103 -24.9% 0.00% $1K 2026-02-03 $3.26
2025 Q3 UNCHANGED 414 0% 0.00% $1K 2025-11-05 $2.87
2025 Q2 ADDED 414 +90 +27.8% 0.00% $998 2025-08-08 $2.20
2025 Q1 REDUCED 20.8% +9.1% 324 -85 -20.8% 0.00% $716 2025-05-02 $2.07
2024 Q4 INITIATED 409 0.00% $2K 2025-02-06 $4.95

FAQ About SBI Securities Co., Ltd. and MRVI

These are the practical questions this page is built to answer before you even open the full history table.

How long has SBI Securities Co., Ltd. reported owning MRVI?

SBI Securities Co., Ltd. reported MRVI across 7 quarterly 13F filings, from 2024 Q4 through 2026 Q2.

What was the largest reported MRVI position in SBI Securities Co., Ltd.'s portfolio?

The largest reported portfolio weight for MRVI was 0.00% in 2024 Q4.

What is the latest reported MRVI position on this page?

The most recent filing on this page is 2026 Q2, when SBI Securities Co., Ltd. reported 311 shares, equal to 0.00% of portfolio, with an estimated market value of $2K.

What does the chart on this MRVI ownership page compare?

The chart compares SBI Securities Co., Ltd.'s quarterly MRVI portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did SBI Securities Co., Ltd. time their MRVI position?

Based on 13F filing dates vs. subsequent MRVI price moves, SBI Securities Co., Ltd. correctly timed 1 out of 4 reported position changes (25%). The annualised alpha on MRVI relative to SPY over the holding period was +9.9%.

← Back to SBI Securities Co., Ltd. Holdings